Establishment and characterization of a recombinant VSV-based pseudotyping platform for studying RSV F-mediated entry and antibody-mediated neutralization
Journal of Virology · 18.11.2026
DOI: 10.1128/jvi.01466-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, online erschienen am 18.11.2026. Verfasst von Luxuan Yang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project, National Key Research and Development Program of China, Guizhou Key Laboratory of Microbio and Infectious Disease Prevention & Control, China.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory tract disease, underscoring the need for safe, scalable platforms to evaluate neutralizing antibodies, and entry-targeting antivirals. Here, we established and characterized a vesicular stomatitis virus (VSV)-based pseudovirus neutralization assay for RSV that uses fusion (F) proteins from RSV A and RSV B strains as functional entry glycoproteins. Key assay parameters were systematically evaluated, including target cell type, F-expression plasmid input, packaging multiplicity of infection, pseudovirus inoculum, detection time point, and cell seeding density. Western blotting confirmed F expression and incorporation into pseudovirus particles, and a GFP reporter-based syncytium assay verified fusion activity. Under the selected assay conditions, the assay showed strong signal linearity, low background, and reproducible reporter readouts in HEK293T cells at 24 h post-infection. Neutralization by monoclonal antibodies targeting six major antigenic sites on RSV F (sites Ø and I–V) supported the functional preservation and accessibility of multiple neutralization-relevant epitopes on the pseudovirus surface. RSV-specific fusion inhibitors selectively blocked both pseudovirus entry and F-mediated cell-cell fusion in a dose-dependent manner, whereas SARS-CoV-2 entry inhibitors had no effect, consistent with the expected virus-specific inhibition profiles. Importantly, pseudovirus neutralization titers showed positive correlations with live-virus neutralization results in both human and mouse sera. Together, these findings establish the VSV-RSV pseudovirus neutralization assay as a robust and scalable platform for measuring F-directed neutralizing activity and for supporting vaccine evaluation, serological surveillance, monoclonal antibody characterization, and antiviral discovery. IMPORTANCE Respiratory syncytial virus (RSV) causes substantial disease in infants, older adults, and immunocompromised individuals, underscoring the need for robust assays to evaluate vaccines, antibodies, and antivirals. Authentic-virus assays remain essential because they measure neutralization in the context of intact RSV, but the involvement of multiple viral components can complicate attribution of neutralization differences specifically to F. The vesicular stomatitis virus-based pseudovirus system developed here uses F as the sole RSV envelope glycoprotein and restricts infection to a single reporter-expressing round, enabling controlled comparisons of F variants, F-directed antibodies, and entry inhibitors. Its positive correlation with authentic-virus neutralization further supports its utility as a complementary platform for mechanistic and comparative studies of RSV F-directed entry and neutralization.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
- Shanghai Sci-Tech Inno Center for Infection & Immunity, National Medical Center for Infectious Diseases, Huashan Hospital, Institute of Infection and Health, Fudan University, Shanghai, China.
- Guizhou Key Laboratory of Microbio and Infectious Disease Prevention & Control, Institute of Virology, The Key and Characteristic Laboratory of Modern Pathogenicity Biology, School of Basic Medicine, Guizhou Medical Uni…
- The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou…
- Department of Infectious Disease, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
- Emergency ICU, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
ORCID-Profile: Luxuan Yang, Xinyi Yu, Yusi Luo, Jingwen Ai, Ke Zhang, Xiaoyu Zhao, Wenhong Zhang
Förderung
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
- National Key Research and Development Program of China
- Guizhou Key Laboratory of Microbio and Infectious Disease Prevention & Control, China
- Central Government Guided Local Science Foundation of Guizhou Province
Zitieren
APA
Yang, L., Luo, M., Lu, Y., Wang, H., Mi, Y., Zhang, L., Lin, L., Wang, H., Sun, B., Sun, Y., Yu, X., Yu, T., Luo, Y., Ai, J., Zhang, K., Zhao, X., & Zhang, W. (2026). Establishment and characterization of a recombinant VSV-based pseudotyping platform for studying RSV F-mediated entry and antibody-mediated neutralization. Journal of Virology. https://doi.org/10.1128/jvi.01466-26
Vancouver
Yang L, Luo M, Lu Y, Wang H, Mi Y, Zhang L, et al. Establishment and characterization of a recombinant VSV-based pseudotyping platform for studying RSV F-mediated entry and antibody-mediated neutralization. Journal of Virology. 2026. doi:10.1128/jvi.01466-26
BibTeX
@article{Yang2026,
author = {Yang, Luxuan and Luo, Meihua and Lu, Yinying and Wang, Huamin and Mi, Yabo and Zhang, Liangjiu and Lin, Luanfeng and Wang, Hongyu and Sun, Binhuang and Sun, Yulei and Yu, Xinyi and Yu, Tianmei and Luo, Yusi and Ai, Jingwen and Zhang, Ke and Zhao, Xiaoyu and Zhang, Wenhong},
title = {Establishment and characterization of a recombinant VSV-based pseudotyping platform for studying RSV F-mediated entry and antibody-mediated neutralization},
journal = {Journal of Virology},
year = {2026},
doi = {10.1128/jvi.01466-26}
}
EUVIMED